Patent directory Β· USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12337019
Vehicles for applying bacteria to skin, scalp, and hair
granted -
US 12338199
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof
granted -
US 12337199
Stable antibody formulation
granted -
US 12337017
Microbiota transfer therapy for Pitt Hopkins Syndrome
granted -
US 12336974
Methods and compositions for preventing and treating auditory dysfunctions
granted -
US 12336985
Methods for shrinking pituitary tumors
granted -
US 12336990
Treatment of prostate cancer
granted -
US 12338249
Crystalline forms of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-Nβ²-methoxyurea
granted -
US 12336980
Dosing regimen for a selective S1P1 receptor agonist
granted -
US 12336835
Neuromodulation to target glucose transporter and/or incretin pathways
granted -
US 12338439
Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLKB1), and kininogen 1 (KNG1) iRNA compositions and methods of use thereof
granted -
US 12338438
Conjugated oligonucleotide compounds, methods of making and uses thereof
granted -
US 12336973
Cancer therapeutic compositions and methods targeting DNAse1L3
granted -
US 12338437
OPA1 antisense oligomers for treatment of conditions and diseases
granted -
US 12337020
Bacteriophage compositions
granted -
US 12338450
Gene therapy constructs for treating Wilson disease
granted -
US 12338274
Anti-VEGF protein compositions and methods for producing the same
granted -
US 2025195525
ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OF SYSTEMIC DISEASES IN CATS
granted -
IT 202300027246
Matrici farmaceutiche per il rilascio prolungato di farmaci
granted -
WO 2025125508
COMBINAISONS DE CORTEXOLONE-17ΞLPHA-PROPIONATE POUR LE TRAITEMENT DE L'ACNΓ
granted -
WO 2025126115
DΓGRADATION DE L'IRAK4 PAR CONJUGAISON D'INHIBITEURS D'IRAK4 AVEC DES LIGANDS DE LIGASE E3 ET PROCΓDΓS D'UTILISATION
granted -
US 12329816
Immunotherapy with metabolic enzyme expression
granted -
US 12329824
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted -
US 12329756
Regulation of eIF4E activity for migraine therapy
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β best for looking up a specific filing or applicant portfolio slice.